Drug details

Vizamyl (flutemetamol f 18 injection)

type of Diagnostic Imaging Agents

Vizamyl (flutemetamol F 18) Injection is a molecular imaging agent used for Positron Emission Tomography (PET) imaging of the brain to estimate beta-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer's Disease (AD) and other causes of cognitive decline.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• flushing, and
• increased blood pressure

The following drugs are related to Vizamyl, either as a replacement or used together:

• Ionetix (ammonia n 13)
• Aricept (donepezil)
• Exelon (rivastigmine tartrate)
• Exelon Patch (rivastigmine transdermal system)
• Neuraceq (florbetaben f 18 injection)
• Octreoscan (indium in -111 pentetreotide kit for intravenous use)
• Jeanatope 1-125 (iodinated 1-125 albumin injection)
• Namenda (memantine hcl)
• Namenda XR (memantine hydrochloride extended release capsules)